The FDA authorized marketing fornew eXciteosa sleep therapy device, eXciteOSA (previously Snoozeal), to decrease snoring and mild obstructive sleep apnea. It is the first anti snoring device used while awake that is planned to improve tongue muscle purpose, which in time can help stop the tongue from collapsing backwards and blocking the airway during sleep.
About eXciteOSA
Manufactured by Signifier Medical Skills, eXciteOSA is a removable tongue muscle inspiration daytime sleep apnoea therapy device that delivers neuromuscular stimulation to the tongue to decrease snoring and mild sleep apnea for patients who are 18 years of age or older. The eXciteOSA device is not intended for patients who have or are supposed of having moderate or severe sleep apnea with an apnea-hypopnea index of 15 or higher.
The electronic anti snoring device works by bringing electrical muscle stimulation through a mouthpiece that sits around the tongue. The eXciteOSA mouthpiece has four electrodes, two situated above the tongue and two situated below the tongue. The anti-snoring electronic device provides electrical influence stimulation act in sittings that consist of a series of electrical beats with rest periods in between. It is used for 20 minutes once a day during a awake state, for a period of 6‐weeks, and once a week afterward.
About Sleep Apnea
Nearly 30 million adults in the U.S. have obstructive sleep apnea, a chronic illness that includes the repeated collapse of the higher airway during sleep. Common warning signs include snoring and unnecessary daytime sleepiness. A common treatment is CPAP treatment, which uses mild levels of air pressure, provided through a mask, to keep the throat open during sleep. Other treatments include oral application therapy, positional therapy, and upper airway encouragement.
FDA Approved Sleep Apnea Devices 